Evidence map›Paper›PMID 20363089›Full record

Trial reportJournal of substance abuse treatment2010

Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder.

Jill M Williams, Marc L Steinberg, Mia Hanos Zimmermann, Kunal K Gandhi, Brooke Stipelman, Patricia Dooley Budsock, Douglas M Ziedonis

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of substance abuse treatment, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 10 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 10 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Individual behavioural counselling for smoking cessation.The Cochrane database of systematic reviews · 2017
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking.European psychiatry : the journal of the Association of European Psychiatrists · 2021
    Trial
  13. Trial
  14. Trial
  15. Expanding Cessation Pharmacotherapy Via Videoconference Educational Outreach to Prescribers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Trial
  16. Trial
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jill M WilliamsUMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08901-2008, USA. jill.williams@umdnj.edu
Marc L Steinberg
Mia Hanos Zimmermann
Kunal K Gandhi
Brooke Stipelman
Patricia Dooley Budsock
Douglas M Ziedonis
Johnson University · USRutgers, The State University of New Jersey · USUniversity of Massachusetts Chan Medical School · US

Funding

Treatment of Addiction to Nicotine in SchizophreniaR01DA015537 · NIDA · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ZIEDONIS, DOUGLAS MICHAEL · 2003 to 2006
$1.8M
Nicotine Intake in Smokers with SchizophreniaR01MH076672 · NIMH · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI WILLIAMS, JILL M · 2006 to 2009
$1.5M
Nicotine Dependence Treatment in Psychiatric ComorbidityK23DA014009 · NIDA · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI WILLIAMS, JILL M · 2001 to 2005
$813k
Treatment Issues In Smokers with SchizophreniaK23DA018203 · NIDA · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI STEINBERG, MARC L · 2004 to 2008
$702k
NIDA NIH HHS K23 DA014009NIDA NIH HHS K23 DA018203NIDA NIH HHS K23-DA 018203-02NIDA NIH HHS K-DA14009-01NIDA NIH HHS R01 DA015537NIDA NIH HHS R01-DA015537NIMH NIH HHS R01 MH076672NIMH NIH HHS R01-MH076672-01A1
6 · The paper itself

Abstract

Compared to the general population, smokers with schizophrenia (SCZ) have reduced success in quitting smoking with usual approaches. This study tested two manualized behavioral counseling approaches-Treatment of Addiction to Nicotine in Schizophrenia (TANS) or Medication Management (MM)-for smokers who were motivated to quit. Individual counseling sessions were provided by mental health clinicians in mental health settings, along with nicotine patch. The two treatments varied in intensity and frequency of sessions. Eighty-seven subjects were randomized and attended at least one treatment session. Twenty-one percent (n = 18) of participants had continuous abstinence at 12 weeks after the target quit date, which was not significantly different between conditions (15.6% TANS vs. 26.2% MM, chi(2) = 1.50, p = .221). Smokers in both groups significantly reduced smoking as measured by cigarettes per day and expired carbon monoxide. Findings support that mental health clinicians can be trained to effectively help smokers with SCZ maintain tobacco abstinence.

Indexed as

Administration, CutaneousAdultBehavior TherapyCombined Modality TherapyDirective CounselingFemaleFollow-Up StudiesHumansMaleMiddle AgedNicotineNicotinic AgonistsPsychotic DisordersSchizophreniaSecondary PreventionSmoking CessationNicotineNicotinic Agonists

Identifiers

PMID20363089
PMCPMC2859987
OpenAlexW2046744172

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.